This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sekisui Chemical Co., Ltd. Announces Year End Dividend for the Year Ended March 31, 2024, Payable on June 21, 2024; Provides Dividend Guidance for the End of Second Quarter of Full Year Ending March 31, 2025 CI
Sekisui Chemical Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Fiscal Year Ending March 31, 2025 CI
Sekisui Chemical Co., Ltd. announces an Equity Buyback for 4,000,000 shares, representing 0.95% for ¥9,200 million. CI
Sekisui Chemical Co., Ltd. authorizes a Buyback Plan. CI
Sekisui Chemical’s Nine-Month Profit Rises Nearly 11% MT
Transcript : Sekisui Chemical Co., Ltd., Q3 2024 Earnings Call, Jan 30, 2024
Sekisui Chemical Co., Ltd. Provides Dividend Guidance for the Full Year Ending March 31, 2024 CI
Sekisui Chemical Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024 CI
Sekisui Chemical Completes 8 Billion Yen Share Buy-back Program MT
Sekisui Chemical Buys Back Over 8 Billion Yen of Shares MT
Tranche Update on Sekisui Chemical Co., Ltd.'s Equity Buyback Plan announced on October 30, 2023. CI
Sekisui Chemical Co., Ltd.'s Equity Buyback announced on October 30, 2023, has closed with 4,000,000 shares, representing 0.94% for ¥8,338 million. CI
Circularise B.V. announced that it has received funding from Sekisui Chemical Co., Ltd. CI
Sekisui’s Attributable Profit up 13.7% in Fiscal H1 due to Gain on Sale of Investment Securities MT
Sekisui Chemical Co., Ltd. announces an Equity Buyback for 4,000,000 shares, for ¥8,800 million. CI
Sekisui Chemical Co., Ltd. Announces Dividend for the Second Quarter End of the Fiscal Year Ending March 31, 2024, Payable on December 1, 2023; Revises Dividend Guidance for the Full Year Ending March 31, 2024 CI
Transcript : Sekisui Chemical Co., Ltd., Q2 2024 Earnings Call, Oct 30, 2023
Sekisui Chemical Co., Ltd. authorizes a Buyback Plan. CI
LATYS Intelligence Inc. announced that it has received funding from Sekisui Chemical Co., Ltd. CI
Sekisui Chemical Co., Ltd., Vantec Co., Ltd. and Tokuyama Sekisui Co.,Ltd. agreed to acquire PVC Pipes and Joints business of Shin-Etsu Polymer from Shin-Etsu Polymer Co.,Ltd. CI
Sekisui Chemical Co., Ltd. Provides Dividend Guidance for the Second Quarter End of Fiscal Year 2024 and Full Year Ended March 31, 2024 CI
Sekisui Chemical Co., Ltd. Provides Earnings Guidance for the First Half of Fiscal 2024 and Year Ended March 31, 2024 CI
Transcript : Sekisui Chemical Co., Ltd., Q1 2024 Earnings Call, Jul 28, 2023
FRD Japan Co. announced that it expects to receive ¥21 billion in funding from a group of investors CI
Sekisui Chemical Closes Buyback of 4 Million Shares MT
Chart Sekisui Chemical Co., Ltd.
More charts
Sekisui Chemical Co., Ltd. is a company that operates in four business segments .The Housing segment is engaged in the manufacture, construction, sale and renovation of unit housing, the sale of land for subdivision, the provision of reform services, as well as the construction and sale of interior items, exterior items and real estate. The Environment and Life Line segment offers vinyl chloride pipe and fittings, polyethylene pipe and fittings, system pipe, aqueduct/water conduit rehabilitation materials, reinforced plastic composite pipes, and building materials, among others. The High-performance Plastics segment offers intermediate films for laminated glass, foamed polyolefin, tapes, particulate for liquid crystal and sensitive materials and test drug, among others. The Others segment is engaged in the manufacture and sale of film type lithium ion battery, as well as the provision of other products and services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2,228 JPY
Average target price
2,272 JPY
Spread / Average Target
+2.00%
Consensus
  1. Stock Market
  2. Equities
  3. 4204 Stock
  4. News Sekisui Chemical Co., Ltd.
  5. Sekisui’s Attributable Profit up 13.7% in Fiscal H1 due to Gain on Sale of Investment Securities